181 related articles for article (PubMed ID: 27748833)
1. The effect of dichloroacetate in canine prostate adenocarcinomas and transitional cell carcinomas in vitro.
Harting T; Stubbendorff M; Willenbrock S; Wagner S; Schadzek P; Ngezahayo A; Murua Escobar HM; Nolte I
Int J Oncol; 2016 Dec; 49(6):2341-2350. PubMed ID: 27748833
[TBL] [Abstract][Full Text] [Related]
2. Dichloroacetate affects proliferation but not apoptosis in canine mammary cell lines.
Harting TP; Stubbendorff M; Hammer SC; Schadzek P; Ngezahayo A; Murua Escobar H; Nolte I
PLoS One; 2017; 12(6):e0178744. PubMed ID: 28591165
[TBL] [Abstract][Full Text] [Related]
3. Dichloroacetate, a selective mitochondria-targeting drug for oral squamous cell carcinoma: a metabolic perspective of treatment.
Ruggieri V; Agriesti F; Scrima R; Laurenzana I; Perrone D; Tataranni T; Mazzoccoli C; Lo Muzio L; Capitanio N; Piccoli C
Oncotarget; 2015 Jan; 6(2):1217-30. PubMed ID: 25544754
[TBL] [Abstract][Full Text] [Related]
4. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
6. Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC.
Stockwin LH; Yu SX; Borgel S; Hancock C; Wolfe TL; Phillips LR; Hollingshead MG; Newton DL
Int J Cancer; 2010 Dec; 127(11):2510-9. PubMed ID: 20533281
[TBL] [Abstract][Full Text] [Related]
7. Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines.
Tataranni T; Agriesti F; Pacelli C; Ruggieri V; Laurenzana I; Mazzoccoli C; Sala GD; Panebianco C; Pazienza V; Capitanio N; Piccoli C
Cells; 2019 May; 8(5):. PubMed ID: 31109089
[TBL] [Abstract][Full Text] [Related]
8. Multi-modality imaging to assess metabolic response to dichloroacetate treatment in tumor models.
Neveu MA; De Preter G; Joudiou N; Bol A; Brender JR; Saito K; Kishimoto S; Grégoire V; Jordan BF; Krishna MC; Feron O; Gallez B
Oncotarget; 2016 Dec; 7(49):81741-81749. PubMed ID: 28082726
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of the HIF-1α/PDK3 signaling axis drives melanoma toward mitochondrial oxidative metabolism and potentiates the therapeutic activity of pro-oxidants.
Kluza J; Corazao-Rozas P; Touil Y; Jendoubi M; Maire C; Guerreschi P; Jonneaux A; Ballot C; Balayssac S; Valable S; Corroyer-Dulmont A; Bernaudin M; Malet-Martino M; de Lassalle EM; Maboudou P; Formstecher P; Polakowska R; Mortier L; Marchetti P
Cancer Res; 2012 Oct; 72(19):5035-47. PubMed ID: 22865452
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate dehydrogenase kinase expression and metabolic changes following dichloroacetate exposure in anoxic human colorectal cancer cells.
Ho N; Coomber BL
Exp Cell Res; 2015 Feb; 331(1):73-81. PubMed ID: 25536473
[TBL] [Abstract][Full Text] [Related]
11. Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a bladder cancer cell line.
Klose K; Packeiser EM; Müller P; Granados-Soler JL; Schille JT; Goericke-Pesch S; Kietzmann M; Murua Escobar H; Nolte I
PLoS One; 2021; 16(9):e0257403. PubMed ID: 34570803
[TBL] [Abstract][Full Text] [Related]
12. In human alloreactive CD4⁺ T-cells, dichloroacetate inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T-cell subset instead of effector T-cell subsets.
Eleftheriadis T; Sounidaki M; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
Mol Med Rep; 2016 Apr; 13(4):3370-6. PubMed ID: 26935268
[TBL] [Abstract][Full Text] [Related]
13. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
Zhang W; Hu X; Zhou W; Tam KY
J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
[TBL] [Abstract][Full Text] [Related]
14. Lipoic acid inhibits cell proliferation of tumor cells in vitro and in vivo.
Feuerecker B; Pirsig S; Seidl C; Aichler M; Feuchtinger A; Bruchelt G; Senekowitsch-Schmidtke R
Cancer Biol Ther; 2012 Dec; 13(14):1425-35. PubMed ID: 22954700
[TBL] [Abstract][Full Text] [Related]
15. Dichloroacetate induces apoptosis in endometrial cancer cells.
Wong JY; Huggins GS; Debidda M; Munshi NC; De Vivo I
Gynecol Oncol; 2008 Jun; 109(3):394-402. PubMed ID: 18423823
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia enhances antitumor activity of dichloroacetate.
Kolesnik DL; Pyaskovskaya ON; Boichuk IV; Solyanik GI
Exp Oncol; 2014 Dec; 36(4):231-5. PubMed ID: 25537215
[TBL] [Abstract][Full Text] [Related]
17. Dichloroacetate induces apoptosis and cell-cycle arrest in colorectal cancer cells.
Madhok BM; Yeluri S; Perry SL; Hughes TA; Jayne DG
Br J Cancer; 2010 Jun; 102(12):1746-52. PubMed ID: 20485289
[TBL] [Abstract][Full Text] [Related]
18. Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells.
Haugrud AB; Zhuang Y; Coppock JD; Miskimins WK
Breast Cancer Res Treat; 2014 Oct; 147(3):539-50. PubMed ID: 25212175
[TBL] [Abstract][Full Text] [Related]
19. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
Kumar A; Kant S; Singh SM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
[TBL] [Abstract][Full Text] [Related]
20. Combinatorial Effect of DCA and Let-7a on Triple-Negative MDA-MB-231 Cells: A Metabolic Approach of Treatment.
Sharma P; Singh S
Integr Cancer Ther; 2020; 19():1534735420911437. PubMed ID: 32248711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
